Viewing data from:

VALPROATE SODIUM

ANDA

VALPROATE SODIUM | A076295 | SAGENT PHARMACEUTICALS

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Valproate Sodium (2023)

Total Spending

$38K

Total Claims

354

Beneficiaries

Avg Cost/Unit

$1.36

Spending Trend

$30K(2019)→$42K(2020)→$48K(2021)→$19K(2022)→$38K(2023)

YoY Change:-17.6%

5yr CAGR:-3.6%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — EQ 100MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Nov 14, 2002

No patent or exclusivity listings for this strength.